Article info
Extended report
Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene
- Correspondence to:
N Ravet
Service de Médecine Interne, Hôpital Tenon, 4 rue de la Chine, 75970 Paris Cedex 20, Paris, France; nathalie.ravet{at}tnn.aphp.fr
Citation
Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene
Publication history
- Accepted March 12, 2006
- First published March 28, 2006.
Online issue publication
August 11, 2006
Article Versions
- Previous version (28 March 2006).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases